Skip to main content
. Author manuscript; available in PMC: 2013 Mar 19.
Published in final edited form as: Leuk Lymphoma. 2011 Feb 21;52(6):994–1002. doi: 10.3109/10428194.2011.557167

Figure 1.

Figure 1

Distribution of initial management choices among elderly patients with diffuse large or diffuse large B-cell lymphoma over time from 1992 to 2002: (A) categorized by initial cytotoxic chemotherapy regimen (ABC, anthracycline-based combination); (B) categorized by initial (immuno)chemotherapy regimen (R, rituximab).